Board-certified rheumatologist Dr. Mahsa Tehrani discusses President Donald Trump’s possible 25% tariff on overseas medication and a new study on the relationship between Ozempic and dementia risk on ‘America Reports.’ Board-certified rheumatologist Dr. Mahsa Tehrani discusses President Donald Trump’s possible 25% tariff on overseas medication and a new study on the relationship between Ozempic and dementia risk on ‘America Reports.’
